Concepedia
Statistics
Publications
25
Citations
3K
H-Index
22
Active since
1984
Affiliations
Peter MacCallum Cancer Centre(Current)
University of California, Los Angeles
Massachusetts General Hospital
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Probity Medical Research
Ivor Caro is an author at Peter MacCallum Cancer Centre specializing in medicine, dermatology, and oncology.
Publications per year
1984–2022
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Grant A. McArthur, Paul B. Chapman, Caroline Robert et al. · The Lancet Oncology · 2014 · 978 citations
Medicine, Oncology, Pharmacology +13
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies
John K. Geisse, Ivor Caro, Jane S. Lindholm et al. · Journal of the American Academy of Dermatology · 2004 · 505 citations
Medicine, Dermatology, Oncology +6
Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial
Craig L. Leonardi, Kim Papp, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology · 2005 · 213 citations
Medicine, Dermatology, Pharmacotherapy +10
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis
Jon M. Hanifin, Amy S. Paller, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2005 · 138 citations
Medicine, Dermatology, Immunology +14
Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib
Christina H. Choe, Grant A. McArthur, Ivor Caro et al. · American Journal of Ophthalmology · 2014 · 112 citations
Medicine, Dermatology, Oncology +12
1–5 of 25